Biotech Behind Oxford’s Coronavirus Vaccine Welcomes AZ’s Big Pharma 'Muscle'

Vaccitech Hails Partner's ‘Aggressive’ Trial Design

Vaccitech
Spun out in 2016, Vaccitech has co-developed with Oxford the adenovirus platform used in the COVID-19 vaccine candidate
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip